October 22, 2025
1 min read

FDA cites Nephron again for ongoing issues the generics manufacturer has failed to resolve

Nephron Pharmaceuticals’ manufacturing facility in West Columbia, South Carolina, is still running afoul of the FDA. In its most recent Form 483 report, the agency has cited several problems that were evident in an August inspection of the facility and that have been ongoing for the last few years.

Leave a Reply

Your email address will not be published.

Previous Story

Anti-science bills hit statehouses, stripping away public health protections built over a century

Next Story

Cambrex to drop $120M to expand US operations amid industry’s breakneck onshoring drive

Previous Story

Anti-science bills hit statehouses, stripping away public health protections built over a century

Next Story

Cambrex to drop $120M to expand US operations amid industry’s breakneck onshoring drive

Latest from Blog

Go toTop